675. Deputy Pádraig O'Sullivan asked the Minister for Health the current state of Ireland's preparedness for utilising the EU's Joint Clinical Assessments (JCA) on clinical trial data in evaluations by the HSE and the National Centre for Pharmacoeconomics (NCPE); when she expects such JCA's to be applied to such evaluations; and if she will make a statement on the matter. [46925/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Pádraig O'Sullivan under the heading Clinical Trials.
5 questions match, newest first.
676. Deputy Pádraig O'Sullivan asked the Minister for Health the guidance that has been issued to Irish marketing authorisation holders regarding the process, timelines, and expectations for considering the EU's Joint Clinical Assessment (JCA) by the HSE and the National Centre for Pharmacoeconomics (NCPE); the way in which JCA reports will be factored into the reimbursement recommendations for treatments; and if she…
783. Deputy Pádraig O'Sullivan asked the Minister for Health if membership of the (CTAC) Clinical Trials Advisory Council has been set; to provide full list of membership; the efforts her Department is making to ensure that Ireland is an attractive place for clinical trials; and if she will make a statement on the matter. [47461/26]
236. Deputy Pádraig O'Sullivan asked the Minister for Health the reason Ireland ranked as the slowest of all EU member states for the time from EU Clinical Trial Regulation approval to the first clinical trial site being ready, at 213 days, for studies commenced between 2023 and 2025; the steps being taken to reduce clinical trial set-up times; and if she will make a statement on the matter. [44375/26]
237. Deputy Pádraig O'Sullivan asked the Minister for Health the number of pharmaceutical industry-sponsored clinical trials commenced in Ireland in each year since 2021; her views on the fact that Ireland initiated far fewer trials than comparable countries such as Denmark over the same period; and if she will make a statement on the matter. [44376/26]